TLR3 and prostate cancer: In colorectal cancer, elevated luminal butyrate supports antitumor M1 polarization through enhanced glycolysis and ROS generation [38], whereas in prostate cancer, increased SCFA flux promotes M2-like macrophage recruitment and tumor progression through TLR3 signaling and autophagy induction [47].